Metabolic syndrome combined with insulin resistance showed great predictive value in evaluating recurrence in patients with atypical endometrial hyperplasia and early endometrial cancer
Abstract Background The metabolic risk score (MRS) is correlated with the progression of endometrial cancer (EC). The purpose of this study was to evaluate the influence of MRS on the recurrence of fertility-sparing treatment for early EC and atypical endometrial hyperplasia (AEH) patients. Methods...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2025-07-01
|
| Ráidu: | BMC Cancer |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12885-025-14481-6 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|